Multiple levels of regulation of megakaryocytopoiesis
- PMID: 2649178
Multiple levels of regulation of megakaryocytopoiesis
Abstract
A working hypothesis for the regulation of megakaryocytopoiesis is described on the basis of current data. The hypothesis proposes that in vivo megakaryocytes are generated by 1) the expansion of clonable progenitor cells into immature megakaryocytes by locally produced (and regulated) interleukin-3 (IL-3) and 2) the development and maturation of immature megakaryocytes by a dual system; by a lineage specific mechanism involving thrombopoietic stimuli in the steady state and thrombocytopenic conditions, and by a lineage nonspecific mechanism via IL-3 in damaged or reconstituting marrow. The hypothesis predicts that if IL-3 is a significant in vivo regulator of megakaryocyte formation and development, receptor for IL-3 should be present on megakaryocytes and may be vestigially on platelets. Small but significant levels of 125I IL-3 were found to bind to platelets from normal mice. The level of binding on platelets was found to be enhanced sevenfold from mice that had received high levels of irradiation followed by bone marrow transplantation. This contrasted with a twofold increase in the level of binding to platelets from mice made acutely thrombocytopenic with antiplatelet serum. The data suggest that IL-3 may be involved in the in vivo regulation of murine megakaryocytopoiesis and may be a significant factor in rebound thrombopoiesis following bone marrow damage.
Similar articles
-
Megakaryocyte growth factors.Immunol Ser. 1990;49:215-29. Immunol Ser. 1990. PMID: 2090252 Review.
-
Modified thrombopoietic response to 5-FU in mice following transplantation of Lin-Sca-1+ bone marrow cells.Exp Hematol. 1995 Feb;23(2):161-7. Exp Hematol. 1995. PMID: 7828673
-
Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production.Exp Hematol. 1997 Feb;25(2):169-76. Exp Hematol. 1997. PMID: 9015217
-
Erythropoiesis, but not thrombocytopoiesis, is affected by the presence of a large amount of subcutaneously implanted bone marrow.Exp Hematol. 1994 Sep;22(10):1011-5. Exp Hematol. 1994. PMID: 8088375
-
Megakaryocytopoiesis: characterization and regulation in normal and pathologic states.Int J Hematol. 1991 Feb;54(1):3-14. Int J Hematol. 1991. PMID: 1954349 Review.
Cited by
-
Manipulations of cholinesterase gene expression modulate murine megakaryocytopoiesis in vitro.Mol Cell Biol. 1990 Nov;10(11):6046-50. doi: 10.1128/mcb.10.11.6046-6050.1990. Mol Cell Biol. 1990. PMID: 2233731 Free PMC article.
-
Thrombopoietin, the Mp1 ligand, is essential for full megakaryocyte development.Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3234-8. doi: 10.1073/pnas.92.8.3234. Proc Natl Acad Sci U S A. 1995. PMID: 7536928 Free PMC article.
-
Thrombopoietin and platelet development.West J Med. 1996 Mar;164(3):209-11. West J Med. 1996. PMID: 8775930 Free PMC article. Review. No abstract available.
-
Increase in mean platelet volume in patients with chronic renal failure treated with erythropoietin.J Clin Pathol. 1994 Feb;47(2):159-61. doi: 10.1136/jcp.47.2.159. J Clin Pathol. 1994. PMID: 8132831 Free PMC article.